Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001511164-13-000302
Filing Date
2013-06-19
Accepted
2013-06-19 09:31:33
Documents
11
Period of Report
2013-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q neurokineform10qq1april3013w.htm 10-Q 259081
8 EXHIBIT 31.1 neurokineexhibit311.htm EX-31.1 7812
9 EXHIBIT 31.2 neurokineexhibit312.htm EX-31.2 7930
10 EXHIBIT 32.1 neurokineexhibit321.htm EX-32.1 5780
11 EXHIBIT 32.2 neurokineexhibit322.htm EX-32.2 5770
  Complete submission text file 0001511164-13-000302.txt   2280658

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT neukf-20130430.xml EX-101.INS 320902
3 XBRL TAXONOMY EXTENSION SCHEMA neukf-20130430.xsd EX-101.SCH 37528
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neukf-20130430_cal.xml EX-101.CAL 2981
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neukf-20130430_def.xml EX-101.DEF 46221
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE neukf-20130430_lab.xml EX-101.LAB 138041
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neukf-20130430_pre.xml EX-101.PRE 122321
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 604 805 7783
Neurokine Pharmaceuticals Inc. (Filer) CIK: 0001464165 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 333-161157 | Film No.: 13920963
SIC: 2834 Pharmaceutical Preparations